Insulin potentiation therapy
One of the major distinctions between cancer cells and normal cells is that cancer cells have lost their ability to utilize oxygen when they are burning glucose for energy production. Because of this, cancer cells must resort to a very primitive and inefficient default method of energy production called fermentation, which is very similar to how a yeast or other primitive organism would survive. As a result, they will utilize 19 times more glucose than normal cells and it is this constant need for glucose that makes this therapy such an effective tool.
During IPT, a small dose of insulin is given to the patient to induce a state of low blood sugar (or hypoglycemia). This dose of insulin is given to trick the cancer cells so that their glucose receptors remain open. After about 30 minutes, the patient begins to have symptoms such as light-headedness and a general weakness, and it is at this point that a much smaller dose (about one tenth of a normal dose) of chemotherapy is administered in hopes of specifically targeting and killing the cancer cells.
Comparing Insulin Potentiation Therapy to conventional chemotherapy
One study using methotrexate, a common chemotherapy drug, showed that IPT was 10,000 times more effective than high dose chemotherapy. The chemotherapy used in IPT will still attack healthy cells, but because much less chemotherapy is used, fewer of the healthy cells are damaged. This treatment can also be given more frequently, giving cancer cells less time to become resistant to the drugs. The patients report having fewer side-effects and retain much more energy during their treatments which they can apply towards other healing modalities.
The benefits of this therapy and how the side effects are much less than traditional therapy
Elaine Gibson heals from stage 4 non-hodgkin’s lymphoma with insulin potentiation therapy and other alternative therapies
- Cellular toxicity is the cause of cancer
- An anticancer diet and lifestyle plan
- Detoxing therapies for the body
- Systemic enzyme therapy